Alzamend Neuro, Inc. (ALZN)

CIK 1677077 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Alzamend Neuro, Inc..

Recent SEC filings

FiledFormAccession number
Sep 10, 202610-Q0001214659-26-011572
Aug 31, 20264/A0001214659-26-011111
Aug 31, 20264/A0001214659-26-011110
Aug 31, 202640001214659-26-011121
Aug 28, 2026PRE 14A0001214659-26-011083
Aug 21, 2026S-10001214659-26-010726
Aug 20, 20264/A0001214659-26-010677
Aug 20, 20263/A0001214659-26-010676
Aug 4, 202640001214659-26-009594
Aug 4, 202650001214659-26-009587
Aug 4, 202640001214659-26-009596
Aug 4, 202630001214659-26-009595
Aug 4, 202650001214659-26-009591
Aug 4, 202650001214659-26-009590
Aug 4, 202650001214659-26-009588
Aug 4, 202650001214659-26-009586
Aug 4, 202650001214659-26-009589
Aug 4, 202650001214659-26-009585
Aug 3, 20268-K0001214659-26-009469
Jul 22, 202610-K0001214659-26-008832
Jul 21, 20268-K0001214659-26-008772
Apr 17, 20268-K0001214659-26-004806
Apr 16, 202640001214659-26-004742
Mar 20, 20268-K0001214659-26-003620
Mar 11, 202610-Q0001214659-26-003166